These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5830976)

  • 21. A new global assay of coagulation and fibrinolysis.
    Goldenberg NA; Hathaway WE; Jacobson L; Manco-Johnson MJ
    Thromb Res; 2005; 116(4):345-56. PubMed ID: 16038720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intelligence scale and the electroencephalogram in progressive muscular dystrophy].
    Tomonaga M; Muro T; Kito S
    Iryo; 1967 Jul; 21(7):800-6. PubMed ID: 5582475
    [No Abstract]   [Full Text] [Related]  

  • 23. [Characteristics of components of the fibrinolytic system in healthy children].
    Sofronova LV
    Vopr Okhr Materin Det; 1975 Jun; 20(6):17-9. PubMed ID: 124506
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison between blood fibrinolytic activity in the legs and arms and its possible role in phlebothrombosis.
    Menon IS; Gibson AL; Weightman D; Dewar HA
    Angiologica; 1971; 8(2):83-8. PubMed ID: 5120567
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of venous occlusion on coagulation and fibrinolytic components in normal subjects.
    Nilsson IM; Robertson B
    Thromb Diath Haemorrh; 1968 Dec; 20(3):397-408. PubMed ID: 5710462
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fibrinolytic response to moderate exercise and platelet adhesiveness in diabetes mellitus].
    Seth HN
    Acta Diabetol Lat; 1973; 10(2):306-314. PubMed ID: 4741835
    [No Abstract]   [Full Text] [Related]  

  • 27. [The blood cogulation and fibrinolytic enzyme system during and after extracorporeal circulation].
    Goldschmidt B; Böröcz L; Haas M; Büky B
    Orv Hetil; 1970 May; 111(18):1027-30. PubMed ID: 5454001
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of some blood clotting and fibrinolytic factors in patients with viral hepatitis].
    Przyjemski J; Chrostowska H; Ellert-Zygadhowska J; Krzysztofowicz J
    Wiad Lek; 1975 Apr; 28(7):533-42. PubMed ID: 1130045
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical biochemical justification for the use of fibrinolysis inhibitors in the therapy of hemorrhages in ENT diseases].
    Veremeenko KN; Gerasimenko NG; Pogorelova LM
    Zh Ushn Nos Gorl Bolezn; 1972; (3):56-61. PubMed ID: 4680879
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fukuyama type congenital muscular dystrophy].
    Osawa M; Hino N
    Ryoikibetsu Shokogun Shirizu; 2001; (35):97-102. PubMed ID: 11556002
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of measured physical performance on fibrinolytic activity and some coagulation factors].
    Radojicić B; Lazić D; Prejić R; Radojicić C; Pekitć B; Trajković B
    Zb Vojnomed Akad; 1975; ():36-40. PubMed ID: 1073634
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fibrinolytic bleedings in urology].
    Lipsky H; Hubmer O
    Z Urol Nephrol; 1969; 62(6):453-61. PubMed ID: 5314209
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of fibrinolysis and intravascular coagulation.
    Pizzuto J; López D; González Llavén J; Romero N; De la Paz Reyna M
    Rev Invest Clin; 1969; 21(4):425-36. PubMed ID: 5408140
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiology of progressive muscular dystrophy in north-western Tuscany.
    Rossi B; Siciliano G; Sartucci F; Bianchi F
    Acta Neurol (Napoli); 1984 Apr; 6(2):125-33. PubMed ID: 6741653
    [No Abstract]   [Full Text] [Related]  

  • 35. Electrophysiological studies in myotonic dystrophy. 1: Potential motor unit parameters and conduction velocity of the motor and sensory peripheral nerve fibres.
    Cruz Martinez A; Ferrer MT; Perez Conde MC
    Electromyogr Clin Neurophysiol; 1984; 24(7):523-35. PubMed ID: 6510351
    [No Abstract]   [Full Text] [Related]  

  • 36. [Muscular dystrophy (clinical and statistical contribution)].
    Cremoncini R; Pratesi C; Quadri A
    Riv Clin Pediatr; 1968; 81(6):1223-7. PubMed ID: 5759399
    [No Abstract]   [Full Text] [Related]  

  • 37. [Granulocyte function in Duchenne's progressive muscular dystrophy].
    Adami Lami C; Bruni A; Forgeschi G; Resti M; Calandi C; Baretti S; De Martino M
    Quad Sclavo Diagn; 1984 Dec; 20(4):460-8. PubMed ID: 6537554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of exhaustive ergometric exercise on blood coagulation, platelet adhesiveness and fibrinolytic activity in untrained young men and women.
    Gaur S; Datta S; Bhargava RP; Rao SV
    Indian J Physiol Pharmacol; 1982; 26(1):65-8. PubMed ID: 7106962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What should the family expect when a child has muscular dystrophy?
    Williams E; Nichols P
    Med Times; 1980 Jul; 108(7):24s-27s, 30s, 32s. PubMed ID: 7401988
    [No Abstract]   [Full Text] [Related]  

  • 40. [Becker muscular dystrophy: clinical analysis, genetic and pathologic correlations].
    Colomer J
    Rev Neurol; 1995; 23 Suppl 3():S408-9. PubMed ID: 7497323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.